Government regulatory influences on opioid prescribing and their impact on the treatment of pain of nonmalignant origin
Open Access
- 31 May 1996
- journal article
- review article
- Published by Elsevier BV in Journal of Pain and Symptom Management
- Vol. 11 (5), 287-298
- https://doi.org/10.1016/0885-3924(95)00203-0
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Benzodiazepine Prescription RegulationJAMA, 1991
- Addiction: definition and implicationsBritish Journal of Addiction, 1990
- Trivializing dependenceBritish Journal of Addiction, 1990
- Behavioural (non‐chemical) addictionsBritish Journal of Addiction, 1990
- The United States experience with oral controlled-release morphine (MS contin tablets).parts i and ii. review of nine dose titration studies and clinical pharmacology of 15-mg, 30-mg, 60-mg, and 100-mg tablet strengths in normal subjectsCancer, 1989
- The Treatment of Cancer PainThe New England Journal of Medicine, 1985
- Management of pain during debridement: a survey of U.S. burn unitsPain, 1982
- Addiction Rare in Patients Treated with NarcoticsThe New England Journal of Medicine, 1980
- How Permanent Was Vietnam Drug Addiction?American Journal of Public Health, 1974
- Undertreatment of Medical Inpatients with Narcotic AnalgesicsAnnals of Internal Medicine, 1973